About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Vancomycin
- Procedure number
- PSUSA/00003097/202001
- Regulatory outcome
- Variation
Documents
Vancomycin: List of nationally authorised medicinal products - PSUSA/00003097/202001
English (EN) (760.25 KB - PDF)
Vancomycin: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003097/202001
English (EN) (120.14 KB - PDF)
български (BG) (159.11 KB - PDF)
español (ES) (99.32 KB - PDF)
čeština (CS) (124.32 KB - PDF)
dansk (DA) (481.82 KB - PDF)
Deutsch (DE) (129.59 KB - PDF)
eesti keel (ET) (361.7 KB - PDF)
ελληνικά (EL) (212.8 KB - PDF)
français (FR) (144.44 KB - PDF)
hrvatski (HR) (188.67 KB - PDF)
íslenska (IS) (147.13 KB - PDF)
italiano (IT) (168.26 KB - PDF)
latviešu valoda (LV) (155.83 KB - PDF)
lietuvių kalba (LT) (154.43 KB - PDF)
magyar (HU) (337.53 KB - PDF)
Malti (MT) (223.65 KB - PDF)
Nederlands (NL) (2.13 MB - PDF)
norsk (NO) (429.87 KB - PDF)
polski (PL) (245.4 KB - PDF)
português (PT) (169.34 KB - PDF)
română (RO) (150.26 KB - PDF)
slovenčina (SK) (162.21 KB - PDF)
slovenščina (SL) (185.63 KB - PDF)
Suomi (FI) (160.86 KB - PDF)
svenska (SV) (119.87 KB - PDF)